JPMorgan Downgrades Teva Pharma (TEVA) to Underweight

November 4, 2013 6:48 AM EST Send to a Friend
Get Alerts TEVA Hot Sheet
Price: $58.00 +2.38%

Rating Summary:
    19 Buy, 13 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 28 | New: 51
Trade TEVA Now!
Join SI Premium – FREE
JPMorgan downgraded Teva Pharma (NYSE: TEVA) from Neutral to Underweight with a price target of $38.00 (from $43.00).

For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.

Shares of Teva Pharma closed at $37.12 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change, Downgrades

Related Entities

JPMorgan

Add Your Comment